Last reviewed · How we verify
NCT03015285
CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT
NA trial testing Cognitive Behavioural Therapy in Generalized Anxiety in 65 participants. Completed in 18 February 2022.
18 February 2022
Quick facts
| Lead sponsor | Nova Scotia Health Authority |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 65 |
| Start date | 5 December 2016 |
| Primary completion | 18 February 2022 |
| Estimated completion | 18 February 2022 |
Drugs / interventions tested
- Cognitive Behavioural Therapy
Conditions studied
- Generalized Anxiety — all drugs for Generalized Anxiety →
- Stress Disorder, Posttraumatic — all drugs for Stress Disorder, Posttraumatic →
- Social Anxiety — all drugs for Social Anxiety →
- Major Depression — all drugs for Major Depression →
Sponsor
Nova Scotia Health Authority — full company profile →
Who can join
19 and older, any sex, with Generalized Anxiety or Stress Disorder, Posttraumatic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adults with high anxiety sensitivity (AS) and a mental health diagnosis of anxiety, depression, or posttraumatic stress will be recruited and will be randomly assigned to either transdiagnostic cognitive behavioural therapy (CBT) for AS or disorder-specific CBT for their primary mental health problem. The study outcomes - AS, anxiety, mood, and substance use symptoms, and functional impairment - will be assessed at pre-and post-treatment and 6 and 12 months post-treatment via standardized self-report measures completed by participants and a standardized diagnostic interview.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03015285
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive Behavioural Therapy
Trials testing the same drug.
- NCT07247370 — Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL) · Phase 1, PHASE2 · not yet recruiting
- NCT05788146 — A Blended Psychological Intervention for Depression After Acquired Brain Injury · NA · unknown
- NCT05691140 — Prevention of Postpartum Anxiety in High-Risk Women · NA · unknown
- NCT05475535 — Can a Self-guided Mobile Phone Application Program Improve Wellbeing in University Students · NA · unknown
- NCT04831385 — The Impact of Cognitive Behavioral Therapy for Insomnia (CBT-I) on Glycemic Control in Older Type 2 Diabetes (T2D) Comor · NA · recruiting
Other recruiting trials for Generalized Anxiety
Currently open trials in the same condition.
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT07189715 — Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence · NA · recruiting
- NCT06973577 — P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety · Phase 3 · active not recruiting
- NCT04751864 — Brain Stimulation & Generalized Anxiety Study · Phase 4 · active not recruiting
Other Nova Scotia Health Authority trials
Trials by the same sponsor.
- NCT03716999 — Starlight Therapy in Palliative Care · not yet recruiting
- NCT06987409 — Continuous Erector Spinae Block for Analgesia Following Lumbar Decompression · NA · not yet recruiting
- NCT06575621 — Knee-hip Surgery Wait-list Support Program · NA · not yet recruiting
- NCT07143162 — YOGA-FIT: Protocol for a Crossover Trial Investigating the Feasibility and Impact of Yoga for People With Stroke · NA · not yet recruiting
- NCT07239999 — Comparing Spinal Anesthesia With 1% Chloroprocaine Versus 1% Mepivacaine in Patients Undergoing Outpatient Primary Total · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03015285 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nova Scotia Health Authority
- Last refreshed: 21 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03015285.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing